Allergy Therapeutics plc (AIM:AGY)

Allergy Therapeutics Revenue

Allergy Therapeutics had revenue of 36.28M GBP in the half year ending December 31, 2025, with 8.07% growth. This brings the company's revenue in the last twelve months to 57.29M, up 2.94% year-over-year. In the fiscal year ending June 30, 2025, Allergy Therapeutics had annual revenue of 55.04M, down -0.28%.

• Revenue (ttm): 57.29M
• Revenue Growth: +2.94%
• P/S Ratio: 11.61
• Revenue / Employee: 98.11K
• Employees: 584
• Market Cap: 664.92M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	55.04M	-155.00K	-0.28%
Jun 30, 2024	55.20M	-4.39M	-7.36%
Jun 30, 2023	59.59M	-13.18M	-18.11%
Jun 30, 2022	72.77M	-11.56M	-13.71%
Jun 30, 2021	84.33M	6.13M	7.83%